1. Home
  2. BNGO vs RLYB Comparison

BNGO vs RLYB Comparison

Compare BNGO & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bionano Genomics Inc.

BNGO

Bionano Genomics Inc.

HOLD

Current Price

$1.73

Market Cap

24.3M

Sector

Industrials

ML Signal

HOLD

Logo Rallybio Corporation

RLYB

Rallybio Corporation

HOLD

Current Price

$0.66

Market Cap

24.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNGO
RLYB
Founded
2003
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.3M
24.1M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
BNGO
RLYB
Price
$1.73
$0.66
Analyst Decision
Strong Buy
Hold
Analyst Count
3
2
Target Price
$6.33
N/A
AVG Volume (30 Days)
303.0K
179.0K
Earning Date
11-13-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$28,720,000.00
$674,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$24.54
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.71
52 Week Low
$1.45
$0.22
52 Week High
$22.80
$1.24

Technical Indicators

Market Signals
Indicator
BNGO
RLYB
Relative Strength Index (RSI) 49.79 57.16
Support Level $1.59 $0.64
Resistance Level $1.88 $0.68
Average True Range (ATR) 0.14 0.04
MACD 0.04 -0.00
Stochastic Oscillator 65.12 65.42

Price Performance

Historical Comparison
BNGO
RLYB

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Share on Social Networks: